Retatrutide, a novel dual activator of the GLP-1 target and glucose-dependent secreted polypeptide (GIP) binding site , is exhibiting promising data in preliminary human studies. Current research https://bookmark-share.com/story21430084/retatrutide-emerging-studies-and-possible-medical-uses